How High Novo Nordisk Could and Should Go for Ablynx Post author:Sam Post published:January 23, 2018 Post category:BioPharma Novo has tried to apply pressure, but the ABLX board and principal shareholder have not been moved. Source: BioSpace You Might Also Like Bruker Corporation Release: Company Announces Acquisition Of Nanoindenting Leader January 23, 2017 San Diego's Mirati Therapeutics Abandons Lead Drug, Shifts Focus November 14, 2017 Bausch & Lomb Introduces Renu Advanced Formula Multi-Purpose Solution May 21, 2017